http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103421746-B

Outgoing Links

Predicate Object
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
filingDate 2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103421746-B
titleOfInvention The monoclonal antibody (EEEV-5E4) of anti-eastern equine encephalitis virus E2 albumen and the B cell epitope polypeptide identified thereof and application
abstract Do you the invention discloses a kind of anti-eastern equine encephalitis virus (Eastern? equine? encephalitis? virus, EEEV) E2 albumen monoclonal antibody (EEEV-5E4) and identify B cell epitope polypeptide and application.The invention also discloses a strain can the hybridoma cell strain of this monoclonal antibody of stably excreting, called after EEEV-5E4, does is its microbial preservation number: CGMCC? No.7008, monoclonal antibody secreted by this hybridoma cell strain can with EEEV? E2 albumen generation specific reaction, and do not react with corresponding negative control.The EEEV that monoclonal antibody of the present invention and this monoclonal antibody identify? E2 protein-specific B cell epitope polypeptide can be used for the reagent preparing differential diagnosis EEEV/VEEV and other Alphavirus, for set up EEEV/VEEV and other virus of alphavirus serology differential diagnostic method and further study alphavirus correlated virus prevention and remedy measures lay a good foundation.
priorityDate 2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10536
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11034
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID34615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68561600
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423512670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460871
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID418289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577968
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11034
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682730
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428054790
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID34615
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11039
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14789
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11039
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11021
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11036

Total number of triples: 42.